SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-058135
Filing Date
2020-05-07
Accepted
2020-05-07 16:32:56
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2015303d1_10q.htm 10-Q 956301
2 EXHIBIT 31.1 tm2015303d1_ex31-1.htm EX-31.1 5558
3 EXHIBIT 31.2 tm2015303d1_ex31-2.htm EX-31.2 5547
4 EXHIBIT 32.1 tm2015303d1_ex32-1.htm EX-32.1 1883
5 EXHIBIT 32.2 tm2015303d1_ex32-2.htm EX-32.2 1863
  Complete submission text file 0001104659-20-058135.txt   8097639

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pahc-20200331.xml EX-101.INS 2567142
7 XBRL TAXONOMY EXTENSION SCHEMA pahc-20200331.xsd EX-101.SCH 46570
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pahc-20200331_cal.xml EX-101.CAL 86277
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pahc-20200331_def.xml EX-101.DEF 163444
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20200331_lab.xml EX-101.LAB 376155
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20200331_pre.xml EX-101.PRE 346737
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 20857005
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences